Aurora Sheboygan Pricing: Ravulizumab Intravenous Solution 300 mg/3 ml at $776.93

Ravulizumab (Ultomiris) is a monoclonal antibody administered via intravenous infusion, primarily used to treat rare blood disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). The Aurora Medical Center Sheboygan County lists the cost of a 300 mg/3 ml dose at $776.93, which generally covers only the medication itself and not additional services like infusion administration, monitoring, or facility fees. Patients considering this treatment should ask for a detailed, itemized estimate to understand all potential charges and confirm insurance coverage prior to scheduling.

Cost Breakdown

• Medication Cost: $776.93 for one 300 mg/3 ml vial of Ravulizumab (Ultomiris).
• Administration Fees: Additional charges may apply for intravenous infusion services.
• Facility Fees: Hospitals or clinics may bill separately for the use of infusion suites or monitoring equipment.
• Monitoring & Labs: Costs for necessary blood tests and monitoring before, during, and after infusion are typically not included in the medication price.

Associated Costs

• Pre-infusion laboratory testing (CBC, renal function, complement activity)
• Post-infusion observation and follow-up appointments
• Possible emergency care for infusion reactions (rare)
• Travel or accommodation for repeated infusions if not local

Insurance & Payment Advice

• Verify insurance coverage and co-pay responsibilities for high-cost specialty drugs like Ravulizumab.
• Ask about prior authorization requirements to avoid claim denials.
• Inquire about copay assistance programs through the manufacturer or third-party organizations.
• Request a pre-treatment cost estimate, including all facility and professional fees.

Side Effect Considerations

• Common side effects include headache, upper respiratory infections, and nausea.
• Serious risks include infusion-related reactions and increased susceptibility to infections (especially meningococcal infections).
• Make sure vaccinations are up to date, especially against meningococcal infections, before starting treatment.

Recovery and Aftercare Tips

• Plan to rest after each infusion and arrange transportation if needed.
• Monitor for any signs of allergic or infusion reactions (fever, chills, rash) and report them immediately.
• Keep all follow-up appointments for bloodwork and assessments as recommended by your healthcare team.

Frequently Asked Questions

• What is Ravulizumab used for? Ravulizumab is prescribed to treat rare blood disorders like paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS), helping prevent destruction of red blood cells.
• How is Ravulizumab administered? It is given as an intravenous infusion, usually in a hospital or specialized clinic setting under medical supervision.
• How often do I need to receive Ravulizumab infusions? After initial loading doses, maintenance infusions are typically administered every 8 weeks, but frequency may vary based on your specific condition and response.
• Does the listed price include all costs associated with treatment? No, the price generally covers only the medication. Additional fees for infusion, monitoring, and facility use are usually billed separately.
• Will my insurance cover Ravulizumab? Coverage varies by insurer and plan. Prior authorization is often required. Contact your insurance provider to confirm your benefits and co-pay responsibilities.
• Are there assistance programs for this medication? Yes, manufacturer and independent programs may offer copay or financial assistance for eligible patients. Ask your healthcare provider or infusion center for information.
• What are the common side effects of Ravulizumab? Headache, upper respiratory tract infections, and nausea are common. Serious risks include infusion reactions and increased infection risk.
• What should I do if I experience a reaction during or after the infusion? Notify your healthcare team immediately if you experience any symptoms such as fever, chills, rash, or difficulty breathing.
• Is there anything I should do to prepare for treatment? Ensure your vaccinations, particularly for meningococcal infection, are up to date, and follow your provider’s instructions regarding lab work and pre-infusion assessments.
• Can I receive infusions at home? Ravulizumab is typically administered in a medical facility, but some patients may qualify for home infusion under the supervision of a healthcare professional. Discuss options with your provider.
• How can I get a detailed cost estimate? Request an itemized estimate from your infusion center or hospital, including all anticipated charges for medication, administration, and facility fees.

Aurora Medical Center Sheboygan County offers a range of medical services, including the administration of specialized medications such as Ravulizumab Intravenous Solution. Ravulizumab, marketed under the brand name Ultomiris, is a monoclonal antibody used primarily to treat certain rare blood disorders, including paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). The cost for a 300 mg/3 ml intravenous solution of Ravulizumab at Aurora Sheboygan is priced at $776.93, reflecting the center’s commitment to providing cutting-edge treatments while maintaining transparency in pricing.

What is Ravulizumab used for? – Ravulizumab is used to treat rare blood disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) by inhibiting the complement system to prevent the destruction of red blood cells.

How is Ravulizumab administered? – Ravulizumab is administered as an intravenous infusion, typically in a hospital or clinical setting, under the supervision of healthcare professionals.

What are the potential side effects of Ravulizumab? – Common side effects of Ravulizumab may include headache, upper respiratory tract infections, and nausea, while serious side effects can include infusion-related reactions and increased risk of infections.

How often is Ravulizumab administered? – The dosing schedule for Ravulizumab typically involves an initial loading dose followed by maintenance doses every eight weeks, depending on the specific condition being treated.

Is Ravulizumab covered by insurance? – Coverage for Ravulizumab varies by insurance provider and plan, so patients should consult with their insurance company to determine their specific coverage and potential out-of-pocket costs.

Why is Ravulizumab so expensive? – The high cost of Ravulizumab is attributed to its status as a biologic drug, the complexity of its development and manufacturing process, and its use in treating rare conditions with limited patient populations.